Tylenol maker: possible FDA label change ‘unsupported by scientific evidence’

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy ...

Starboard's Jeff Smith 'thrilled to own' Kenvue at current valuation

Kenvue stock drops 30% YTD, but Starboard's Jeff Smith remains optimistic, citing leadership changes and brand improvements.

Tylenol maker urges FDA to reject request for an autism warning

Last month, Trump warned of a link between autism and acetaminophen use in pregnancy, going against advice from medical ...

Tylenol’s maker pushes back against possible label change linking pain reliever’s use in pregnancy to autism

Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...

Kenvue urges US FDA to reject request for Tylenol’s autism warning

(Reuters) - Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during pregnancy, after President Donald ...

Kenvue asks FDA to not change Tylenol label on potential autism risk

On Oct. 17, Kenvue filed a response to the Citizen Petition, arguing against the need to add a pregnancy/autism risk warning ...